Go Pro
NYSE:BSX

Boston Scientific Q3 2026 Earnings Report

Boston Scientific logo
$43.30 -0.35 (-0.79%)
Closing price 10/1/2026 03:59 PM Eastern
Extended Trading
$43.32 +0.02 (+0.05%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific EPS Results

Actual EPS
N/A
Consensus EPS
$0.77
Beat/Miss
N/A
One Year Ago EPS
N/A

Boston Scientific Revenue Results

Actual Revenue
N/A
Expected Revenue
$5.13 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Boston Scientific Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Wednesday, October 28, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

Boston Scientific Earnings Headlines

They're not telling you how bad this could get
Valuations are stretched to levels seen only a handful of times in the past century, while a growing debt spiral and lingering tariff shocks ripple through supply chains. Parkview Capital's new Market Crash Survival Guide breaks down what's really happening beneath the market's record highs and how retirement savers are responding.tc pixel
How Big Could BSX Stock's Next Fall Be?
See More Boston Scientific Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Boston Scientific? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Boston Scientific and other key companies, straight to your email.

About Boston Scientific

Boston Scientific (NYSE:BSX) is a global medical technology company that develops, manufactures and markets devices used to diagnose and treat a broad range of medical conditions. Its products are designed to support minimally invasive procedures across areas including cardiovascular care, endoscopy, urology, pelvic health and neuromodulation.

The company’s portfolio includes devices for interventional cardiology and peripheral interventions, electrophysiology and cardiac rhythm management, gastrointestinal and pulmonary procedures, kidney stone and prostate treatments, urinary and pelvic health, and chronic pain management. Boston Scientific also provides technologies used in the diagnosis and treatment of structural heart conditions and other complex diseases.

Founded in 1979, Boston Scientific is headquartered in Marlborough, Massachusetts, and serves hospitals, healthcare professionals and patients in markets around the world. The company operates through a global network of research, manufacturing and commercial operations. Michael F. Mahoney serves as chairman and chief executive officer.

View Boston Scientific Profile